<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>医麦客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-18T11:26:36+08:00</updated>
  <subtitle>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>NK细胞药物开发的最新进展——对话Tavotek公司CSO Mark Chiu博士</title>
    <updated>2020-12-18T07:26:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/njZ4UoIe4PiTtCV4-lbsTg</id>
    <link href="https://mp.weixin.qq.com/s/njZ4UoIe4PiTtCV4-lbsTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球第三款CAR-T疗法在欧盟获批上市丨医麦猛爆料</title>
    <updated>2020-12-18T07:26:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/jVPPT0PlvSpLSuHYNdOW9w</id>
    <link href="https://mp.weixin.qq.com/s/jVPPT0PlvSpLSuHYNdOW9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature子刊：国内溶瘤病毒产品唤醒T细胞并克服检查点阻断耐药，溶瘤策略持续火热丨医麦新观察</title>
    <updated>2020-12-18T07:26:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/0gdvlRoCll6R6KK6YdyU8Q</id>
    <link href="https://mp.weixin.qq.com/s/0gdvlRoCll6R6KK6YdyU8Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>火热报名中！如何对细胞治疗企业进行合理估值</title>
    <updated>2020-12-18T07:26:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/ZivTrnoEQ6ZyVyhUeoO06A</id>
    <link href="https://mp.weixin.qq.com/s/ZivTrnoEQ6ZyVyhUeoO06A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>7款竞争性PD-1/L1角逐医保目录门票，未来的创新药如何接招灵魂砍价？丨医麦新观察</title>
    <updated>2020-12-17T13:15:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/-MZEKKK-50tG18n5PLOp0g</id>
    <link href="https://mp.weixin.qq.com/s/-MZEKKK-50tG18n5PLOp0g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>首款突破性治疗ADC药物？荣昌生物HER2 ADC拟纳入突破性治疗品种丨医麦猛爆料</title>
    <updated>2020-12-17T13:15:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/3Fb7emhYLJeoffbAd77Y9A</id>
    <link href="https://mp.weixin.qq.com/s/3Fb7emhYLJeoffbAd77Y9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>厉兵秣马，恒驭生物浙江检测中心落成</title>
    <updated>2020-12-17T13:15:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/ETJPHDrUwJeIPyk8Etga3A</id>
    <link href="https://mp.weixin.qq.com/s/ETJPHDrUwJeIPyk8Etga3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」海普洛斯CEO许明炎：精准医疗助力打造未来中国医药领域全新局面</title>
    <updated>2020-12-17T13:15:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/D7qq2RnK0DCx4pwX-KGyEQ</id>
    <link href="https://mp.weixin.qq.com/s/D7qq2RnK0DCx4pwX-KGyEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>王振义教授：解决患者的问题，让患者少一点痛苦、少花一点钱</title>
    <updated>2020-12-17T13:15:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/mmfmeo96oPXMXF7LCGlyRA</id>
    <link href="https://mp.weixin.qq.com/s/mmfmeo96oPXMXF7LCGlyRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>北京市卫健委正式发布《CAR-T细胞免疫疗法临床研究伦理审查指南》</title>
    <updated>2020-12-17T13:15:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/F29-Bm93lfXfw8U9PhKHxw</id>
    <link href="https://mp.weixin.qq.com/s/F29-Bm93lfXfw8U9PhKHxw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>基因治疗市场规模持续扩大，预计2027年将达到356.7亿美元丨医麦新观察</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/UTR8pWnAPZJWJXu8ookSqA</id>
    <link href="https://mp.weixin.qq.com/s/UTR8pWnAPZJWJXu8ookSqA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Nature子刊：外泌体药物逐渐步入临床开发阶段，成为下一代潜在的重磅药物载体技术丨医麦新观察</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/PcxyYnLLGexPr6KEE30JiA</id>
    <link href="https://mp.weixin.qq.com/s/PcxyYnLLGexPr6KEE30JiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ASH 2020丨邱录贵教授：CNCT19联合ASCT在复发/难治性大B细胞淋巴瘤中疗效及安全性良好</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/u_Ttp1C5qpcq-c8Fr8LapQ</id>
    <link href="https://mp.weixin.qq.com/s/u_Ttp1C5qpcq-c8Fr8LapQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>翟博教授：实体瘤CAR-T治疗——远方千万里，已经在路上</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/2dWXvPW25tRoqhhmDFwTyA</id>
    <link href="https://mp.weixin.qq.com/s/2dWXvPW25tRoqhhmDFwTyA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>「峰客访谈」八通生物董事长胡小龙：从检测创新入手，应对新冠疫情持久战</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/koKmPctBYjlGGfRQPkjlZA</id>
    <link href="https://mp.weixin.qq.com/s/koKmPctBYjlGGfRQPkjlZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>相约深圳｜新一代生物技术革命到来！看合成生物学如何颠覆人类认知</title>
    <updated>2020-12-16T11:18:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/PNJt9ktMhxffi_2wqxTIpw</id>
    <link href="https://mp.weixin.qq.com/s/PNJt9ktMhxffi_2wqxTIpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药融资丨宜明细胞完成1.2亿元A轮融资，全面提高GMP病毒载体产能</title>
    <updated>2020-12-15T18:06:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/iHNo_yQRE_CkQCcBKqVeFQ</id>
    <link href="https://mp.weixin.qq.com/s/iHNo_yQRE_CkQCcBKqVeFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>传奇生物的CD4 CAR-T获FDA批准临床丨医麦猛爆料</title>
    <updated>2020-12-15T18:06:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/V5U0TWOZPJ6tOtFwCBwWFQ</id>
    <link href="https://mp.weixin.qq.com/s/V5U0TWOZPJ6tOtFwCBwWFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新增线上直播丨人类遗传资源与生物医药注册法规官方解读</title>
    <updated>2020-12-15T18:06:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/HQ91zQiVr3TrS2baBtwyHg</id>
    <link href="https://mp.weixin.qq.com/s/HQ91zQiVr3TrS2baBtwyHg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>​徐开林教授：CAR-T存在前线治疗的可能，有待解决副作用和高费用问题</title>
    <updated>2020-12-15T18:06:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/JcXMcwp6_GGwQeDsJWBK6g</id>
    <link href="https://mp.weixin.qq.com/s/JcXMcwp6_GGwQeDsJWBK6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>